Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug

Glenmark Pharmaceuticals has received tentative approval by the United States Food& Drug Administration (USFDA) for Axitinib tablets in the strength of 1 mg and 5 mg, the company said in a regulatory filing.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news